Clarifying the confusion between poligeenan, degraded carrageenan, and carrageenan: A review of the chemistry, nomenclature, and

Carrageenan degraded carrageenan food additive poligeenan polydisperse

Journal

Critical reviews in food science and nutrition
ISSN: 1549-7852
Titre abrégé: Crit Rev Food Sci Nutr
Pays: United States
ID NLM: 8914818

Informations de publication

Date de publication:
2019
Historique:
pubmed: 15 6 2018
medline: 20 2 2020
entrez: 15 6 2018
Statut: ppublish

Résumé

Carrageenan (CGN) is a common food additive that has been widely used for decades as a gelling, thickening and stabilizing agent. Carrageenan has been proven safe for human consumption; however, there has been significant confusion in the literature between CGN and the products of intentional acid-hydrolysis of CGN, which are degraded CGN (d-CGN) and poligeenan (PGN). In part, this confusion was due to the nomenclature used in early studies on CGN, where poligeenan was referred to as "degraded carrageenan" (d-CGN) and "degraded carrageenan" was simply referred to as carrageenan. Although this nomenclature has been corrected, confusion still exists resulting in misinterpretation of data and the subsequent dissemination of incorrect information regarding the safe dietary use of CGN. The lack of understanding of the molecular weight distribution of CGN has further exacerbated the issue. The significant differences in chemistry, manufacture, and protein reactivity of CGN versus d-CGN and PGN are reviewed, in addition to the

Identifiants

pubmed: 29902080
doi: 10.1080/10408398.2018.1481822
doi:

Substances chimiques

Food Additives 0
Polysaccharides 0
poligeenan 53973-98-1
Carrageenan 9000-07-1

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

3054-3073

Auteurs

James M McKim (JM)

IONTOX, LLC, Kalamazoo, MI, USA.

Jamin A Willoughby (JA)

IONTOX, LLC, Kalamazoo, MI, USA.

William R Blakemore (WR)

Celtic Colloids Inc., Topsham, ME, USA.

Myra L Weiner (ML)

TOXpertise, LLC, Princeton, NJ, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH